RPTX
USDRepare Therapeutics Inc. Common Shares
$1.780-0.040 (-2.198%)
Real-time Price
Healthcare
Biotechnology
Canada
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.820
High
$1.855
Low
$1.780
Volume
0.15M
Company Fundamentals
Market Cap
76.5M
Industry
Biotechnology
Country
Canada
Trading Stats
Avg Volume
0.13M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.89Current $1.780High $4.069
Related News
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.
View more
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.
View more
BusinessWire
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy data from the Phase
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.